Patient-initiated follow-up of early endometrial cancer: a potential to improve post-treatment cardiovascular risk?

por Johnson, Racheal Louise, Choy, Cheng
Publicado 2021

Barriers to Immunotherapy in Ovarian Cancer: Metabolic, Genomic, and Immune Perturbations in the Tumour Microenvironment

por Johnson, Racheal Louise, Cummings, Michele, Thangavelu, Amudha, Theophilou, Georgios, de Jong, Diederick, Orsi, Nicolas Michel
Publicado 2021

The Uncertain Benefit of Adjuvant Chemotherapy in Advanced Low-Grade Serous Ovarian Cancer and the Pivotal Role of Surgical Cytoreduction

por Johnson, Racheal Louise, Laios, Alexandros, Jackson, David, Nugent, David, Orsi, Nicolas Michel, Theophilou, Georgios, Thangavelu, Amudha, de Jong, Diederick
Publicado 2021

Immune Checkpoint Inhibitors Targeting the PD-1/PD-L1 Pathway in Advanced, Recurrent Endometrial Cancer: A Scoping Review with SWOT Analysis

por Johnson, Racheal Louise, Ganesan, Subhasheenee, Thangavelu, Amudha, Theophilou, Georgios, de Jong, Diederick, Hutson, Richard, Nugent, David, Broadhead, Timothy, Laios, Alexandros, Cummings, Michele, Orsi, Nicolas Michel
Publicado 2023